Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › budesonide

budesonide

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of budesonide

35 trials tracked of budesonide: 20 in phase 3 or 4 and 6 with published results. The most-cited published study has 109 citations.

35Trials tracked
20Phase 3 & 4
0Recruiting
6With published results
Phase distribution
Phase 4 6 Phase 3 14 Phase 2 10 Phase 1 1 Other / NA 4
  1. Phase 3 Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis Completed · 109 cited
  2. Phase 3 Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis Completed · 109 cited
  3. Phase 4 The Impact Of The Addition Of Budesonide To Low-Pressure, High-Volume Saline Sinus Irrigation For Chronic Rhinosinusitis Completed · 78 cited
  4. Phase 3 Altitude Sickness Prevention and Efficacy of Comparative Treatments Completed · 37 cited
  5. Phase 4 Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPD Completed · 19 cited
  6. Phase 3 A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma Completed · 19 cited
Show 29 more trials
  1. Phase 4 Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPD Completed
  2. Phase 4 Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis) Completed
  3. Phase 4 Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans Completed
  4. Phase 4 NasoNeb Delivery of an Intranasal Steroid Completed
  5. Phase 3 Dupilumab in Chinese Adult Participants With CRSwNP Completed
  6. Phase 3 The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis Completed
  7. Phase 3 Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room. Completed
  8. Phase 3 Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) Completed
  9. Phase 3 Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma Completed
  10. Phase 3 CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST) Completed
  11. Phase 3 Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients Completed
  12. Phase 3 (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets Completed
  13. Phase 3 The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room Completed
  14. Phase 3 New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a Day Completed
  15. Phase 2 Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease Completed
  16. Phase 2 Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients Completed
  17. Phase 2 LIPS-B: Lung Injury Prevention Study With Budesonide and Beta Completed
  18. Phase 2 Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi Completed
  19. Phase 2 Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis Completed
  20. Phase 2 An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide Completed
  21. Phase 2 Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis Completed
  22. Phase 2 Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer Completed
  23. Phase 2 Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy Completed
  24. Phase 2 A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo Completed
  25. Phase 1 A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy Adults Completed
  26. N/A The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery Completed
  27. N/A Role of microRNAs in T Cell-Driven Inflammation in Asthma Completed
  28. N/A Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population Completed
  29. N/A Acupuncture Therapy for COVID-Related Olfactory Loss Completed

Showing the 35 most-cited and recently-updated of 35 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Dupilumab and cendakimab show moderate-to-high certainty benefit for dysphagia in eosinophilic esophagitis
Allergy & Immunology Sys. Review
Dupilumab and cendakimab show moderate-to-high certainty benefit for dysphagia in eosinophilic esophagitis New data shows different treatments for eosinophilic esophagitis symptoms
This network meta-analysis evaluates various treatments for eosinophilic esophagitis in adolescents and adults. The analysis indicates that …
New research identifies specific medications that help improve swallowing difficulties for adults and teens with eosinophilic esophagitis.
Sep 1, 2026
Respiratory trajectories vary by gestational age in infants born before 26 weeks' gestation
Pulmonology & Critical Care RCT
Respiratory trajectories vary by gestational age in infants born before 26 weeks' gestation New data tracks breathing progress for very premature infants
This post-hoc exploratory analysis of a randomized controlled trial involved 601 infants born before 26 weeks' gestation receiving surfactan…
A new look at clinical data helps doctors better predict and manage breathing needs for babies born before 26 weeks of pregnancy.
Aug 3, 2026
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) for COPD Maintenance
Pulmonology & Critical Care FDA Approval
FDA Approves Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) for COPD Maintenance FDA approves new triple-combination inhaler Breztri Aerosphere for COPD.
The FDA approved Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) for maintenance treatment of COPD. It is a triple-combin…
The FDA approved Breztri Aerosphere, a triple-combination inhaler, for the long-term treatment of chronic obstructive pulmonary disease (COP…
FDA May 2, 2026
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma
Allergy & Immunology RCT
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma New Asthma Drug Cuts Attacks Without Recent Crisis
This phase 3 randomised, double-blind, double-dummy, parallel-group trial evaluated budesonide-glycopyrronium-formoterol fumarate dihydrate …
A new asthma combo therapy improves breathing and lowers severe flare-up risk for patients who haven't had a recent emergency room visit.
Apr 14, 2026